Colistin is an old drug, and its use has recently resurged because of increasing antibiotic resistance in gram-negative bacteria such as Acinetobacter baumannii. Although the colistin resistance rates in gram-negative bacteria are currently not high, many colistin-resistant isolates are being identified and the possibility of horizontal transmission of colistin resistance has increased because of the plasmid-borne colistin resistance gene mcr-1 (mobilized colistin resistance). In this review, we have discussed colistin resistance in A. baumannii. In addition, we have reviewed an abnormal phenomenon called colistin dependence in A. baumannii
Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-negative b...
Recently, plasmid-mediated and, therefore, transferable bacterial polymyxin resistance was discover...
PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete los...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
: Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectru...
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Acinetobacter baumannii has emerged as a major cause of healthcare-associated infections. It commonl...
AbstractColistin has been re-introduced into clinical practice for the treatment of carbapenem-resis...
Colistin is drug of choice for treatment of carbapenem-resistant Acinetobacter baumannii infections....
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-negative b...
Recently, plasmid-mediated and, therefore, transferable bacterial polymyxin resistance was discover...
PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete los...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
: Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectru...
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Acinetobacter baumannii has emerged as a major cause of healthcare-associated infections. It commonl...
AbstractColistin has been re-introduced into clinical practice for the treatment of carbapenem-resis...
Colistin is drug of choice for treatment of carbapenem-resistant Acinetobacter baumannii infections....
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-negative b...
Recently, plasmid-mediated and, therefore, transferable bacterial polymyxin resistance was discover...
PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete los...